Angiomyolipoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (32 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Angiomyolipoma}} | {{Angiomyolipoma}} | ||
{{CMG}}''' Associate Editor-In-Chief:''' {{CZ}} | {{CMG}}''' Associate Editor-In-Chief:''' {{CZ}}, {{Faizan}}, {{Rekha}} | ||
== | ==Overview== | ||
The incidence is | The [[incidence]] of [[angiomyolipoma]] is approximately 30 per 100,000 individuals worldwide. Females are more commonly affected with [[angiomyolipoma]] than males. [[Angiomyolipoma]] commonly affects individuals older than 40 years of age. | ||
==Gender== | ==Epidemiology and Demographics== | ||
Angiomyolipoma | ===Prevalence=== | ||
* [[Angiomyolipoma]] occurs in more than 70% of cases with renal manifestations of [[tuberous sclerosis]].<ref name="pmid17003820">{{cite journal| author=Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA| title=Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors. | journal=Kidney Int | year= 2006 | volume= 70 | issue= 10 | pages= 1777-82 | pmid=17003820 | doi=10.1038/sj.ki.5001853 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17003820 }}</ref><ref name="pmid170038202">{{cite journal| author=Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA| title=Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors. | journal=Kidney Int | year= 2006 | volume= 70 | issue= 10 | pages= 1777-82 | pmid=17003820 | doi=10.1038/sj.ki.5001853 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17003820 }}</ref><ref name="pmid15327383">{{cite journal| author=Bissler JJ, Kingswood JC| title=Renal angiomyolipomata. | journal=Kidney Int | year= 2004 | volume= 66 | issue= 3 | pages= 924-34 | pmid=15327383 | doi=10.1111/j.1523-1755.2004.00838.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15327383 }}</ref> | |||
===Incidence=== | |||
* The [[incidence]] of [[angiomyolipoma]] is approximately 30 per 100,000 individuals worldwide. | |||
===Gender=== | |||
* Females are more commonly affected with [[angiomyolipoma]] than males. The female to male ratio is approximately 4 to 1. | |||
===Age=== | |||
* [[Angiomyolipoma]] commonly affects individuals older than 40 years of age.<ref name="pmid20635448">{{cite journal| author=Koo KC, Kim WT, Ham WS, Lee JS, Ju HJ, Choi YD| title=Trends of presentation and clinical outcome of treated renal angiomyolipoma. | journal=Yonsei Med J | year= 2010 | volume= 51 | issue= 5 | pages= 728-34 | pmid=20635448 | doi=10.3349/ymj.2010.51.5.728 | pmc=2908871 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20635448 }}</ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Vascular medicine]] | |||
Latest revision as of 11:55, 6 November 2019
|
Angiomyolipoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Angiomyolipoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Angiomyolipoma epidemiology and demographics |
|
Risk calculators and risk factors for Angiomyolipoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2], Faizan Sheraz, M.D. [3], Rekha, M.D.
Overview
The incidence of angiomyolipoma is approximately 30 per 100,000 individuals worldwide. Females are more commonly affected with angiomyolipoma than males. Angiomyolipoma commonly affects individuals older than 40 years of age.
Epidemiology and Demographics
Prevalence
- Angiomyolipoma occurs in more than 70% of cases with renal manifestations of tuberous sclerosis.[1][2][3]
Incidence
- The incidence of angiomyolipoma is approximately 30 per 100,000 individuals worldwide.
Gender
- Females are more commonly affected with angiomyolipoma than males. The female to male ratio is approximately 4 to 1.
Age
- Angiomyolipoma commonly affects individuals older than 40 years of age.[4]
References
- ↑ Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA (2006). "Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors". Kidney Int. 70 (10): 1777–82. doi:10.1038/sj.ki.5001853. PMID 17003820.
- ↑ Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA (2006). "Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors". Kidney Int. 70 (10): 1777–82. doi:10.1038/sj.ki.5001853. PMID 17003820.
- ↑ Bissler JJ, Kingswood JC (2004). "Renal angiomyolipomata". Kidney Int. 66 (3): 924–34. doi:10.1111/j.1523-1755.2004.00838.x. PMID 15327383.
- ↑ Koo KC, Kim WT, Ham WS, Lee JS, Ju HJ, Choi YD (2010). "Trends of presentation and clinical outcome of treated renal angiomyolipoma". Yonsei Med J. 51 (5): 728–34. doi:10.3349/ymj.2010.51.5.728. PMC 2908871. PMID 20635448.